Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Equity
Direct
Sector - Healthcare

NAV: ₹ 17.8 as on 27-09-2022

Fund Performance
zero opening, trading, fund transfer fee
497 people have invested ₹ 13.6L in mutual fund in the last three months

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
Pros
Hold on while we find any good points for this fund.
Cons
3Y returns in the bottom 25% of the category

Fund Performance

Return
1M
3M
6M
1Y
3Y
This Fund
-0.3%
3.4%
-6.8%
-12.8%
20.3%
Benchmark
-2.8%
9.4%
0.4%
-2.4%
16.2%
Category
0.2%
4.9%
-5.3%
-11.2%
23.9%
About the Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on  11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.

Key parameters

1) Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has a NAV of 17.76 as on 27-09-2022.

2) Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has 476 Cr worth of assets under management (AUM) as on 31-07-2022 and is less than category average.

3) The fund has an expense ratio 1.04 %.

Fund Overview

Expense ratio
Expense ratio
1.04%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹476 Cr
Inception Date
Inception Date
11 July, 2019
Min Lumpsum/SIP
Min Lumpsum/SIP
₹1000/₹500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
64.89%

Fund Distribution

  • Equity 96.8%
  • Debt & Cash 3.2%
Size breakup
Large cap
55.9%
Mid cap
21.3%
Small cap
19.6%

Sector Allocation

Aug'22

Jul'22

Jun'22

Health

98.3%

Consumer Defensive

1.7%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings30
Equity Holdings28
Debt Holdings2

What changed

in last one month
  • Scheme
  • Portfolio
AUM decreased by 9.4 Cr in last 1M
Aug'22 return underperformed benchmark

Change in AUM

Aug'22
₹ 475.6 Cr
Jul'22
₹ 485.1 Cr
Jun'22
₹ 462.1 Cr

Fund Returns vs Benchmark

Aug'22
5.32%
9.49%
Jul'22
5.32%
9.49%
Jun'22
-2.45%
-4.94%
Fund Return
Benchmark Return

Concentration Analysis

Fund
Aug'22
Jul'22
Jun'22
No of Holdings
30
29
29
Top 5 Company Concentration
48.6%
48%
46.2%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (15.6%)
Sun Pharmaceuticals Industries Ltd (16.2%)
Sun Pharmaceuticals Industries Ltd (15%)
No of Sectors
3
3
3
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (95.2%)
Health (94.8%)
Health (95.1%)

Fund Manager

Dhaval Shah

Dhaval Shah

Managing this fund since 11 July 2019

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
Aditya Birla Sun Life Equity Savings Fund Direct Plan Growth
8.82%
8.49%
Aditya Birla Sun Life Reg Savings Fund Direct Plan Growth
9.96%
7.59%
Aditya Birla Sun Life Equity Hybrid '95 Fund Direct Plan Growth
12.18%
13.84%

AMC details

Address
Aditya Birla Sun Life AMC Ltd,One World Centre, Tower 1, 17th Floor,Jupiter Mill Compound, 841, Senapati Bapat Marg,Elphinstone Road
Phone
+912243568000
Fund House
Aditya Birla Sun Life AMC Ltd

Fund Highlights

meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 19.38% since inception which is more than its category average return of 17.86%
Fund Allocations

Fund Allocations

This fund has an allocation of 96.8% in Equity, 0% in Debt and 3.2% in Cash related instruments
AUM size ₹476 Cr

AUM size ₹476 Cr

This fund has AUM of ₹476 Cr which is less than its category average of ₹ 1340 Cr
Expense Ratio 1.04%

Expense Ratio 1.04%

This fund has an expense ratio of 1.04% which is less than its category average expense ratio of 1.53%

Frequently Asked Questions

The current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is 17.76.
Existing (Absolute + CAGR)
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
-0.34%
-0.34%
6 Month Returns
-6.82%
-6.82%
1 Year Returns
-12.77%
-12.77%
3 Years Returns
73.95%
20.26%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.04 as on August 2022
476 Cr as on August 2022
Sun Pharmaceuticals Industries Ltd(15.63%),Cipla Ltd(10.02%),Dr Reddy's Laboratories Ltd(8.84%),Apollo Hospitals Enterprise Ltd(7.72%),Divi's Laboratories Ltd(6.39%) as on August 2022
Health(95.18%),Cash Equivalent(3.2%),Consumer Defensive(1.62%) as on August 2022
The alpha ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
-1.96
0.38
-
As on month end.
The alpha for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
0.92
0.89
-
As on month end.
The Beta for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
-1.18
0.82
-
As on month end.
The sharpe ratio for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
14.53
20.3
-
As on month end.
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
1.66
Dhaval Shah is the fund manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
The Exit load of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is 1%